Exhibit 99.1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, Mark E. Strome, Strome Group, Inc., Strome Investment Management, LP, Strome Mezzanine Fund, LP and Strome Mezzanine Fund II, LP agree to the joint filing on behalf of each of them a statement on Schedule 13D/A (including amendments thereto, if any) with respect to the shares of common stock of Zivo Bioscience, Inc., a Michigan corporation, and that this Agreement may be included as an Exhibit to such joint filing.

 

Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D/A and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

 

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of February 27, 2026.

 

  /s/ Mark E. Strome
  Mark E. Strome
     
  Strome Group, Inc.
     
  By: /s/ Mark E. Strome
  Name: Mark E. Strome
  Its: President
     
  Strome Investment Management, LP
     
  By: Strome Group, Inc.
  Its: General Partner
     
  By: /s/ Mark E. Strome
  Name: Mark E. Strome
  Its: President
     
  Strome Mezzanine Fund, LP
   
  By: Strome Mezzanine Fund II, LP
    the surviving entity of the merger between
    Strome Mezzanine Fund, LP and Strome
    Mezzanine Fund II, LP
     
  By: Strome Investment Management, LP
  Its: General Partner
     
  By: Strome Group, Inc.
  Its: General Partner
     
  By: /s/ Mark E. Strome
  Name: Mark E. Strome
  Its: President
     
  Strome Mezzanine Fund II, LP
   
  By: Strome Investment Management, LP
  Its: General Partner
     
  By: Strome Group, Inc.
  Its: General Partner
     
  By: /s/ Mark E. Strome
  Name: Mark E. Strome
  Its: President